TY - JOUR
T1 - A presurgical study of lecithin formulation of green tea extract in women with early breast cancer
AU - Lazzeroni, Matteo
AU - Guerrieri-Gonzaga, Aliana
AU - Gandini, Sara
AU - Johansson, Harriet
AU - Serrano, Davide
AU - Cazzaniga, Massimiliano
AU - Aristarco, Valentina
AU - MacIs, Debora
AU - Mora, Serena
AU - Caldarella, Pietro
AU - Pagani, Gianmatteo
AU - Pruneri, Giancarlo
AU - Riva, Antonella
AU - Petrangolini, Giovanna
AU - Morazzoni, Paolo
AU - DeCensi, Andrea
AU - Bonanni, Bernardo
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Epidemiologic data support an inverse association between green tea intake and breast cancer risk. Greenselect Phytosome (GSP) is a lecithin formulation of a caffeine-free green tea catechin extract. The purpose of the study was to determine the tissue distribution of epigallocatechin-3-O-gallate (EGCG) and its effect on cell proliferation and circulating biomarkers in breast cancer patients. Twelve early breast cancer patients received GSP 300 mg, equivalent to 44.9 mg of EGCG, daily for 4 weeks prior to surgery. The EGCG levels were measured before (free) and after (total) enzymatic hydrolysis by HPLCMS/ MS in plasma, urine, breast cancer tissue, and surrounding normal breast tissue. Fasting blood samples were taken at baseline, before the last administration, and 2 hours later. Repeated administration of GSP achieved levels of total EGCG ranging from 17 to 121 ng/mL in plasma. Despite a high between-subject variability, total EGCG was detectable in all tumor tissue samples collected up to 8 ng/g. Median total EGCG concentration was higher in the tumor as compared with the adjacent normal tissue (3.18 ng/g vs. 0 ng/g, P 0.02). Free EGCG concentrations ranged from 8 to 65.8 ng/mL in plasma (P between last administration and 2 hours after <0.001). Free EGCG plasma levels showed a significant positive correlation with the Ki-67 decrease in tumor tissue (P 0.02). No change in any other biomarkers was noted, except for a slight increase in testosterone levels after treatment. Oral GSP increases bioavailability of EGCG, which is detectable in breast tumor tissue and is associated with antiproliferative effects on breast cancer tissue.
AB - Epidemiologic data support an inverse association between green tea intake and breast cancer risk. Greenselect Phytosome (GSP) is a lecithin formulation of a caffeine-free green tea catechin extract. The purpose of the study was to determine the tissue distribution of epigallocatechin-3-O-gallate (EGCG) and its effect on cell proliferation and circulating biomarkers in breast cancer patients. Twelve early breast cancer patients received GSP 300 mg, equivalent to 44.9 mg of EGCG, daily for 4 weeks prior to surgery. The EGCG levels were measured before (free) and after (total) enzymatic hydrolysis by HPLCMS/ MS in plasma, urine, breast cancer tissue, and surrounding normal breast tissue. Fasting blood samples were taken at baseline, before the last administration, and 2 hours later. Repeated administration of GSP achieved levels of total EGCG ranging from 17 to 121 ng/mL in plasma. Despite a high between-subject variability, total EGCG was detectable in all tumor tissue samples collected up to 8 ng/g. Median total EGCG concentration was higher in the tumor as compared with the adjacent normal tissue (3.18 ng/g vs. 0 ng/g, P 0.02). Free EGCG concentrations ranged from 8 to 65.8 ng/mL in plasma (P between last administration and 2 hours after <0.001). Free EGCG plasma levels showed a significant positive correlation with the Ki-67 decrease in tumor tissue (P 0.02). No change in any other biomarkers was noted, except for a slight increase in testosterone levels after treatment. Oral GSP increases bioavailability of EGCG, which is detectable in breast tumor tissue and is associated with antiproliferative effects on breast cancer tissue.
UR - http://www.scopus.com/inward/record.url?scp=85020310477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020310477&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-16-0298
DO - 10.1158/1940-6207.CAPR-16-0298
M3 - Article
AN - SCOPUS:85020310477
VL - 10
SP - 363
EP - 369
JO - Cancer Prevention Research
JF - Cancer Prevention Research
SN - 1940-6207
IS - 6
ER -